Condition
Alcohol-associated Hepatitis
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (2)
Trial Status
Not Yet Recruiting3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07465588Not ApplicableNot Yet Recruiting
Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease
NCT07060638Phase 2RecruitingPrimary
Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
NCT06750588Phase 1Not Yet RecruitingPrimary
Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis
NCT06582329Phase 2Not Yet RecruitingPrimary
Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis
Showing all 4 trials